Skip to main content
2026 ASCRS Annual Scientific Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
CME
CME
Invitation/Ticketed Event
Invitation/Ticketed Event
Invited Lectureship
Invited Lectureship
Award Recipient
Award Recipient
Live Streamed Session
Live Streamed Session
Nurses Contact Hours
Nurses Contact Hours
Self-Assessment
Self-Assessment
Live Q&A and Polling
Live Q&A and Polling
Social
Social
Industry
Industry

Session:: Declined or Withdrawn Presentations

EP472 - Bibliometric and Visual Analysis of Traditional Chinese Medicine for Irritable Bowel Syndrome Based on VOSviewer

Saturday, May 9, 2026
4:00 AM - 5:00 AM ET

    Declined Speaker(s)

  • Danlu Zhang

    Resident physicians
    Shuguang Hospital affiliated to Shanghai
    Hospital
    Shanghai, Shanghai, China (People's Republic)

    Disclosure information not submitted.

    View ePoster

    • Author(s)

  • Haiyan Wu

    Resident physicians
    Shuguang Hospital affiliated to Shanghai
    Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
    Shanghai, Shanghai, China (People's Republic)

    All disclosed relationships have been reviewed and managed prior to the start of this activity. Any relevant relationships will be listed below. This individual has no financial relationships to disclose

    • Senior Author(s)

  • yP

    yunhua Peng, n/a

    Associate Chief Physician
    Shuguang Hospital affiliated to Shanghai
    Shanghai, Shanghai, China (People's Republic)

    Disclosure information not submitted.

Purpose/Background: To employ bibliometric methods for a visual analysis of the global research landscape, collaborative networks, and knowledge structure of Traditional Chinese Medicine (TCM) in the treatment of Irritable Bowel Syndrome (IBS).

Methods/Interventions: Literature published between 2000 and 2024 on TCM for IBS was retrieved from the Web of Science Core Collection. VOSviewer software was used to analyze collaborations among countries, institutions, and authors, and to perform co-occurrence analyses on keywords.

Results/Outcomes: A total of 594 articles were included. The annual publication output has shown significant growth since 2017, indicating increasing academic interest. China held a dominant core position in this field, with key research institutions concentrated in universities of Chinese medicine and comprehensive universities in Shanghai, Beijing, Guangzhou, etc. However, international collaboration remained relatively weak. A core group of authors had formed, but their collaborative networks exhibited characteristics of "regional concentration and insufficient cross-team collaboration." Research hotspots primarily focus on randomized controlled trials (RCTs), mechanisms of efficacy (e.g., 5-HT, brain-gut axis, inflammatory factors), TCM syndrome differentiation, and specific therapies and formulas such as acupuncture and Tongxie Yaofang. Research fronts have evolved from initial clinical efficacy observations to explorations of underlying mechanisms (e.g., the brain-gut axis, visceral hypersensitivity) and evaluations of patient quality of life.

Conclusion/Discussion: Research on TCM for IBS has developed into a stable landscape dominated by China. Future efforts should focus on deepening inter-institutional collaboration, elucidating molecular mechanisms, and promoting high-quality clinical research to enhance international influence.